Teva Buys Allergan's Generic Drug Unit for $40.5 Billion

Filed under: Company News, Mergers & Acquisitions, Drug Companies, Healthcare Industry, Consumer Issues

AlamyBy DANIEL ESTRINJERUSALEM -- Teva Pharmaceutical Industries said Monday it is purchasing Dublin-based Allergan's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.Statements from both companies say the deal will see Allergan receive $33.75 billion in cash and shares of Teva valued Monday at $6.75...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Company News [+]    Mergers [+]    Acquisitions [+]    Drug Companies [+]    Healthcare Industry [+]    Consumer Issues [+]    AlamyBy DANIEL ESTRINJERUSALEM [+]    Teva Pharmaceutical Industries [+]    Monday [+]    Dublin [+]    Allergan [+]    Statements [+]    Teva [+]   

More #news: